TriLink BioTechnologies and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap mRNA Capping TechnologyBusiness Wire • 4 days ago
TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has signed a non-exclusive License and Supply Agreement...
Share to Feed
TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has announced the grand opening of its new cGMP mRNA...
China Universal Asset Management Co. Ltd. raised its position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 351.0% during the 4th quarter, according to its most recent...
Closed a $6.0 million convertible note in a private placement, with a conversion price of $1.79 and no warrantsReported positive topline data from First-In-Human Phase 1 trial demonstrated clinical...
This is a signal that MRVI's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
SAN DIEGO, March 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled...
Investors considering a purchase of Maravai LifeSciences Holdings Inc (MRVI) stock, but tentative about paying the going market price of 7.80/share, might benefit from considering selling puts...
This is a signal that MRVI's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
QRG Capital Management Inc. acquired a new stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI Free Report) during the third quarter, according to its most recent filing with the SEC...
Related Stocks: NAS:MRVI...